Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin
- 28 February 1991
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 20 (2) , 221-225
- https://doi.org/10.1016/0360-3016(91)90094-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The interaction of trans-ddp [PtCl2(NH3)2] with low doses of radiation in mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesBritish Journal of Cancer, 1989
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radiosensitization of hypoxic cells at low dosesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The Use of Solid-state Image Sensor Technology to Detect and Characterize Live Mammalian Cells Growing in Tissue CultureInternational Journal of Radiation Biology, 1986
- Carboplatin as a potentiator of radiation therapyCancer Treatment Reviews, 1985
- Radiation and Platinum Drug InteractionInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1985
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Survival measurements at low doses: oxygen enhancement ratioBritish Journal of Cancer, 1982